Chile is tendering for radiopharmaceutical project in prostate cancer

Chile is tendering for radiopharmaceutical project in prostate cancer

The Chilean Nuclear Energy Commission (CCHEN) is formulating a research and development (R & D) project aimed at developing a radiopharmaceutical for the detection of prostate cancer.

The proposal, which will be presented to the Corfo Crea and Valida contest for its co-financing, allows for the intervention of an investor or collaborator entity that is involved in achieving the results of said project.

Review requirements and conditions here.

http://www.cchen.cl/wp-content/uploads/2019/01/Lllamado-a-presentar-declaraci%C3%B3n-de-interes_Corfo_2019-1.pdf

About Author

Arnaud Lefevre

Arnaud Lefevre is the Chief Executive Officer of Dynatom International. Arnaud is in charge of the international development of the business portfolio.